Velan Capital Investment Management LP Protara Therapeutics, Inc. Transaction History
Velan Capital Investment Management LP
- $58.2 Million
- Q2 2025
A detailed history of Velan Capital Investment Management LP transactions in Protara Therapeutics, Inc. stock. As of the latest transaction made, Velan Capital Investment Management LP holds 2,139,000 shares of TARA stock, worth $6.57 Million. This represents 11.14% of its overall portfolio holdings.
Number of Shares
2,139,000
Previous 1,667,800
28.25%
Holding current value
$6.57 Million
Previous $7.1 Million
8.77%
% of portfolio
11.14%
Previous 12.25%
Shares
5 transactions
Others Institutions Holding TARA
# of Institutions
81Shares Held
27.7MCall Options Held
37.2KPut Options Held
65.1K-
Janus Henderson Group PLC London, X04.1MShares$12.6 Million0.01% of portfolio
-
Blackstone Inc New York, NY1.91MShares$5.86 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.8MShares$5.53 Million0.0% of portfolio
-
Acorn Capital Advisors, LLC New York, NY1.75MShares$5.38 Million3.47% of portfolio
-
Catalio Capital Management, LP New York, NY1.63MShares$4.99 Million1.03% of portfolio
About Protara Therapeutics, Inc.
- Ticker TARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,267,400
- Market Cap $34.6M
- Description
- Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...